Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2c (DMDA1)

Alias:

Gamma-Sarcoglycanopathy

Limb-Girdle Muscular Dystrophy Due to Gamma-Sarcoglycan Deficiency

Lgmd2c

Gamma-Sarcoglycan-Related Limb-Girdle Muscular Dystrophy R5

Lgmd Due to Gamma-Sarcoglycan Deficiency

Limb-Girdle Muscular Dystrophy Type 2c

Gamma-Sarcoglycan-Related Lgmd R5

Lgmd Type 2c

Severe Childhood Autosomal Recessive Muscular Dystrophy North African Type

Autosomal Recessive Duchenne-Like Muscular Dystrophy Type 1

Muscular Dystrophy, Limb-Girdle, Type 2c

Deficiency of Sarcoglycan Gamma

Maghrebian Myopathy

Scarmd

Dmda1

Favorite

Basic Information

Medical Symptom

Gene & Mutation

Related Drugs

Disease Model

References Literature

Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2c, also known as gamma-sarcoglycanopathy, is related to myoglobinuria and muscular dystrophy, limb-girdle, autosomal recessive 1. An important gene associated with Autosomal Recessive Limb-Girdle Muscular Dystrophy Type 2c is SGCG (Sarcoglycan Gamma), and among its related pathways/superpathways are Cardiac conduction and DREAM Repression and Dynorphin Expression. The drug Pharmaceutical Solutions has been mentioned in the context of this disorder. Affiliated tissues include tongue and heart, and related phenotypes are macroglossia and elevated circulating creatine kinase concentration

Related ID：

MALACARDS：ATS246